Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Agnosia × Diathermy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hyperthermia 17 Sarcoma 6 Prostatic Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Melanoma 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Adenoma, Pleomorphic 1 Prehypertension 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Pelvic Pain 1 Ovarian Neoplasms 1 Obesity 1 Neurofibrosarcoma 1 Neoplasms, Radiation-Induced 1 Metabolic Syndrome 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1

Interventions

Bupivacaine 9 Ketamine 8 Dexmedetomidine 7 Analgesics, Opioid 7 Ropivacaine 6 Anesthesia, General 6 Acetaminophen 6 Lidocaine 5 Fentanyl 5 Acupuncture Therapy 5 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Morphine 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 Transcutaneous Electric Nerve Stimulation 2 Tea 2 Pregabalin 2 Oxycodone 2 Magnesium Sulfate 2 Levobupivacaine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡